Firm at a glance
Nordic Capital is a platform private equity firm founded in 1989 and headquartered in Stockholm, per its own website [S1].
What they buy
Nordic Capital’s portfolio reflects a concentration in four primary sectors: healthcare, technology and payments, financial services, and services and industrial technology, according to publicly disclosed portfolio companies [S2]. The firm appears to pursue platform investments across these verticals, with healthcare representing the largest single sector concentration among its disclosed holdings. Recent transaction activity demonstrates continued appetite for both new platforms and add-on acquisitions within existing portfolio companies [S3].
Portfolio
Healthcare
Platform investments include corpuls (acquired 2023), Vivecti Group (acquired 2018), Sunrise Medical (acquired 2015), ArisGlobal, The Binding Site, and LEO Pharma [S2].
Technology & Payments
Platform investments include Regnology (acquired 2020), Macrobond, iLOQ, Itiviti (acquired 2012), Cint, Siteimprove, Anaqua, TradingHub, and ActiveViam [S2].
Financial Services
Platform investments include NOBA Bank Group (acquired 2017), Max Matthiessen, Nordnet (acquired 2017), Qred, Sambla Group, and 1741 Group [S2].
Services & Industrial Tech
Platform investments include Autocirc (acquired 2023), Cary Group, and Sensio [S2].
Recent activity (last 24 months)
* Flowa Technology AB acquisition (2025) [S3]
* Liberis acquisition (2025) [S3]
* Fed Reporter add-on acquisition by Regnology (2025) [S3]
* TradingHub acquisition (2025) [S3]
* 1741 Group acquisition (2025) [S3]
* Sensio add-on acquisition in Spain (2025) [S3]
* Esser add-on acquisition by corpuls (2025) [S3]
* Replay gene therapy platform add-on by LEO Pharma (2025) [S3]
* Cint Group AB exit (2025) [S3]
* NOBA Bank Group AB exit (2025) [S3]
How this firm fits a seller
Nordic Capital operates with approximately €39 billion in assets under management as of January 2026, suggesting capacity for substantial platform investments [S1]. The firm maintains offices across 11 cities including New York, London, Frankfurt, Seoul, and Hong Kong, indicating global reach despite its Nordic origins [S1]. Recent transaction history shows four add-on acquisitions in 2025 alone, suggesting an active buy-and-build strategy for owner-operators considering joining existing platforms [S3]. The firm’s 2025 exits of Cint Group and NOBA Bank Group demonstrate ongoing portfolio turnover and realization activity [S3].
Sources
[S1] https://www.nordiccapital.com/about-us/ (as of 2026-01-15)
[S2] https://www.nordiccapital.com/portfolio-cases/ (as of 2026-01-15)
[S3] https://www.nordiccapital.com (as of 2026-01-15)
Frequently asked questions
Does Nordic Capital buy Healthcare businesses?
Yes, healthcare represents a significant portion of Nordic Capital’s portfolio, with six disclosed platform investments including corpuls (acquired 2023), Vivecti Group (acquired 2018), and Sunrise Medical (acquired 2015) [S2]. The firm completed a healthcare add-on in 2025 when corpuls acquired Esser [S3].
What companies has Nordic Capital acquired recently?
Nordic Capital’s recent platform acquisitions include Flowa Technology AB, Liberis, TradingHub, and 1741 Group, all completed in 2025 [S3]. The firm also completed multiple add-on acquisitions during 2025, including Fed Reporter for Regnology and Esser for corpuls [S3].
Where is Nordic Capital based and how big is the firm?
Nordic Capital is headquartered in Stockholm and operates offices in 11 cities including Copenhagen, Frankfurt, Helsinki, London, New York, Seoul, and Hong Kong [S1]. The firm reports approximately €39 billion in assets under management as of January 2026 [S1].
Is Nordic Capital still actively acquiring?
Yes, Nordic Capital completed multiple acquisitions throughout 2025, including four new platform investments and at least four add-on acquisitions for existing portfolio companies [S3]. This recent transaction volume suggests ongoing active investment activity.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.